Digital Subscription

tool name

close
tool goes here

U.S. not slow in drug approval, study says

Researchers say the U.S. approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing new drugs.

Published: May 17, 2012 at 12:05 a.m. PDT
0 comments

Researchers say the U.S. approved more new medicines in less time than Europe and Canada in the last decade, challenging long-standing criticisms that the Food and Drug Administration lags behind its peers in clearing new drugs.

Between 2001 and 2010, the FDA’s typical review of a new drug was about 15 percent faster than those by the European Medicines Agency and Health Canada, its counterparts abroad, according to a study published Wednesday by the New England Journal of Medicine. The analysis was done by researchers at Yale and the Mayo Clinic.

JOIN THE DISCUSSION | Register here

We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.

SPORTS
SOUTH SOUND
BLOGS
CONTESTS

Similar stories

  • New drug made available to those with diabetes

    The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar.

  • FDA approves anticlotting drug that targets strokes

    The Food and Drug Administration said Friday that it approved an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It’s a potential blockbuster in a new category of medicines to prevent strokes.

  • 2012 US medicine sales show shifts by drug type

    U.S. sales levels for many widely used drug categories shifted significantly in 2012, with sales in some classes declining sharply due to an infusion of cheaper new generic pills. Other categories grew, mainly with the introduction of new, generally expensive medicines.

  • FDA approves once-a-day inhaler from Glaxo

    The Food and Drug Administration says it has approved a new once-a-day inhaler drug from GlaxoSmithKline for patients with chronic lung disease.

  • Ferndale will accept prescription drugs for disposal

    FERNDALE - Residents can drop off unwanted prescription and over-the-counter drugs at Haggen Pharmacy and the police station.

    Narcotics and other controlled substances must be taken in their original bottles to the police station, 2220 Main St. Other medicines can be dropped off at Haggen, 1815 Main St.

    The city's new prescription takeback program is promoted as an alternative to throwing pills in unsecured trash bins, flushing them down the toilet or storing them after they expire. The aim is to prevent water contamination, accidental poisoning and the spread of illegal narcotics among drug addicts.